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Coronary stents.Abstract Background: Recurrent ischemic symptoms after coronary stenting require imaging
assessment to rule-out in-stent restenosis or occlusion.
Aim: To evaluate role of multi-detector computed tomography in assessment of coronary artery
stents.
Patients and methods: Twenty-four patients were referred to assess coronary stents.
All were subjected to history taking, clinical examination and computed tomography angiography
of coronary arteries using 320-row multi-detector computed tomography.
Results: There were totally sixty-three coronary artery stents. Only six stents were non-
interpretable. Where forty-eight patent, while nine stents showed in-stent restenosis of significant
degree (P50%), most stents 3.0 mm diameter.
Conclusion: Multi-detector computed tomography is considered convenient and reliably non-
invasive imaging modality for assessment of suspected coronary stents with large diameter.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Coronary artery stenting has become the most important non-
surgical treatment for symptomatic coronary artery disease.
However, in-stent restenosis occurs at a relatively high rate
and this problem has led to the routine use of invasive angiog-
raphy for assessing stent patency (1).
The clinical incidence of restenosis after coronary stent
insertion is 20–35% for bare metal stents and 5–10% for
drug-eluting stents, but it can be higher in certain subsets of
lesions such as long stenosis, bifurcation lesions or lesions in
small coronary arteries (2).
Fig. 1 54-years old male patient with recurrent typical chest pain
3 months after PCI to treat LAD bifurcation lesion. (a) Left
anterior oblique view of 3D volume rendered image showing two
kissing stents inserted at mid LAD and D2 with good contrast
opacification of distal LAD and D2 beyond the stents. Severe
proximal LAD stenosis is evident. The LCx and its obtuse
marginal branches are patent without significant stenosis. (b)
Curved planar reformatted image showing patent mid LAD stent
with no in-stent restenosis. The distal LAD beyond the stent is
patent. The proximal LAD shows severe stenosis by concentric
soft plaque. (c) Curved planar reformatted image showing patent
stent. Patent D2 segment.
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has resulted in further reductions in the occurrence of resteno-
sis, in-stent thrombosis, however neointimal hyperplasia may
still occur and cause partial or complete stent obstruction (3).
Whereas the clinical diagnosis of stent occlusion due to
thrombosis is usually straightforward in patients with a recent
stent implantation and with a subsequent onset of acute
myocardial ischemia leading to acute myocardial infarction,
the assessment of in-stent restenosis is more challenging (4).
Although coronary angiography is the clinical gold stan-
dard and it is a very effective diagnostic tool for detecting such
in-stent restenosis, it’s clearly an invasive procedure with its
associated morbidity and mortality risks (5).
Therefore, a non-invasive, less expensive technique for
detecting in-stent restenosis would be of great interest and used
for following up (6).
Magnetic resonance imaging is a versatile cardiac imaging
modality, and its ability to depict coronary artery stents is
impaired by susceptibility artifacts induced by stent itself (7).
The latest generation of MDCT scanners, which offer a
smaller voxel size, faster gantry rotation speed, higher spatial
and temporal resolution as well as reconstruction of up to
320 sections per gantry rotation, provides an appealing alter-
native for non-invasive luminal assessment in patients with
chest pain after coronary stent placement (8).
MDCT also can be useful to assess the condition of the
whole coronary tree, as it provides information about the
number, severity, and location of coronary lesions. MDCT
enables reduction in further examinations such as stress
echocardiography and scintigraphy needed because of a posi-
tive or inconclusive test result (9).
Beside demonstrating in-stent stenosis and thrombosis,
MDCT can effectively evaluate other stent complications such
as stent fractures, migrations, buckling, or collapse and other
rare complications such as perforations and aneurysms (10).
The aim of our study was to evaluate the role of multidetec-
tor CT in the assessment of coronary artery stents in patients
exhibiting recurrent chest pain or having positive results for
myocardial ischemia on doing other non-invasive tests during
their follow-up.
2. Patients and methods
A total number of 24 patients were enrolled in this study for
multislice CT angiography of coronary arteries between Jan-
uary 2014 and October 2015. Those patients were referred to
diagnostic radiology and medical imaging department at
Tanta University Educational Hospital from cardiology
department and private clinics (see Figs. 1–5).
Written informed consent was obtained from all patients
participated in this study after full explanation of the benefits
and risks of the procedure. They were informed about any
unexpected risks that may appear during the course of
this study. All patients’ related information were kept
confidential.
2.1. Inclusion criteria
 Patient having recurrent chest pain after previous coronary
artery stenting. Asymptomatic patient underwent previous coronary stent-
ing and shows positive results for myocardial ischemia dur-
ing regular follow-up on doing non-invasive tests such as
thallium scan, stress echocardiography or stress ECG.
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 Patient who is clinically unstable to withstand the duration
of CT examination or cannot tolerate the required breath
holding time for examination (10 s).
 Patient with history of allergy to IV contrast material or has
impaired renal function.
 Patients with BMI > 40.
Every patient was subjected to the following:
 Proper history taking and clinical examination.
 Radiological examination Multi-slice CT angiography of
coronary arteries.
 Instructions:
 Fasting 4–6 h before scan. Encourage water intake till one
hour before scan.
 Avoid caffeine products and smoking and exercise one day
before scan.
 Stop taking phosphodiesterase inhibitors used to treat erec-
tile dysfunction or pulmonary hypertension.
 Patient preparation: Explanation of procedure with reassur-
ance to relief anxiety.
 Heart rate control: optimum H.R. below 65 bpm (12pa-
tients), no medication given.
 Patients with higher H.R. were given oral B-blockers or
5.0 mg oral Ivabradine one hour before the scan.
 Eight patients with H.R. 65–75 bpm were given 50 mg oral
Metoprolol *Four Patients with H.R. above 75 bpm were
given 100 mg oral metoprolol.
 At scanner room: Patients were given gown to put on and
then instructed to lie supine on scanner table with arms
raised above their heads.
 ECG electrodes were applied to chest wall after skin prepa-
ration with alcohol and ECG trace was monitored
 Intra-venous canulla (16–22) in right anticubital vein was
connected and test injection with saline was done
 5.0 mg sublingual Isosorbid dinitrate was given.
 Contrast media injection:
 Non-ionic contrast media (Ultravist 370 mgI/ml; Bayer
Healthcare, Berlin, Germany) was injected through the
peripherally inserted IV cannula using dual-head powered
automatic injector (Stellant D, Medrad, Indianola, PA,
USA) followed by 50 cc saline flushing. The amount of con-
trast material and injection flow rate was adapted according
to patient body habitus and scan time as follows:
 Contrast volume (in ml) = (scan time + 10)  injection
flow rate.
 The injection flow rates were adapted according to kV used;
100 kV: 4.0 ml/s, 120 kV: 5.0 ml/s & 135 kV: 6.0 ml/s.
 CT scan protocol: All patients were scanned with 320-row
multidetector CT scanner (Aquilion One, Toshiba Medical
Systems, Otawara, Japan) installed at Tanta University
Educational Hospital through these steps:
 Initial scanogram AP and lateral projection for automatic
radiation dose calculation and for planning scan range from
carina down to the apex of the heart.
 Automatic bolus tracking technique was used to detect the
arrival of contrast material at descending aorta. The ROI
was placed at descending aorta at mid heart level withtrigger threshold set at 230 HU. Repetitive low-dose moni-
toring examinations (120 kV, 50 mAs, 0.5-s scanning time)
were performed 10 s after contrast medium injection began.
When trigger threshold was reached, scan started immedi-
ately after breath holding command.
2.3. Image acquisition
 Acquisition parameters: 0.35 s gantry rotation time, variable
mA according to patient body habitus (range: 250–
580 mA), variable kv according to patient body habitus
(range: 80–135 kv).
 Prospective ECG gating was used with volume scanning
method. Single heart beat acquisition was routinely per-
formed in those with heart rate below 65 bpm and the scan
window was set at 70–80% of R–R interval. In those with
heart rate ranged from 65 to 70 bpm, the scanning window
was set to 30–80% of R–R interval to include end systolic
phase.
 Heart rate remained above 70 bpm at four (16.7%) patients
due to suboptimal response to oral medications used and
anxiety. In those patients, CT acquisition was done using
multiple heart beats to improve temporal resolution with
scanning window set manually to cover 30–80% of the
R–R interval.
2.4. *Image-reconstruction
Images were reconstructed at 0.5 mm slice thickness and
0.5 mm interval with smooth and sharp reconstruction kernels
(FC03 & FC05 respectively) at 75% of R–R interval and at the
best diastolic phase. The scan field of view was set to as small
as possible for better spatial resolution. Post processing: The
reconstructed images were transferred to workstation (Vitrea
Fx, Vital Images, USA) to form multiplanar reformatted
images in axial, sagittal and coronal planes. Also maximum
intensity projection, 3D volume rendered images and curved
planar reformations were obtained.
2.5. Image-analysis
2.5.1. Assessment of image quality
A stent was considered assessable when the stent lumen was
visible and contrast attenuation of the lumen could be evalu-
ated qualitatively without the influence of partial volume
effects, metal artifacts of stents, or cardiac motion artifacts.
Each stent was assigned an image quality score of 1 (good
image quality, no artifacts affecting evaluation of the stent),
2 (adequate image quality, mild to moderate artifacts, blurring
but acceptable for clinical diagnosis), or 3 (poor image quality,
uninterpretable with severe artifacts making stent evaluation
impossible) according to the criteria used for assessability.
Reduced image quality was evaluated in relation to stent loca-
tion, diameter and strut thickness.
2.5.2. Assessment of stent lumen
Stent lumen was assessed at workstation using curved planar
reformatted images while 3D volume rendered images were
Fig. 2 60-year old male patient exhibits dyspnea and mild chest
pain one year after PCI to treat RCA and LAD lesions. (a) Left
anterior oblique view of 3D volume rendered image showing the
stent inserted at proximal LAD with good opacification of mid
and distal LAD beyond the stent. The visible segment of LM and
proximal LAD as well as LCx and its obtuse marginal branches is
well opacified. (b) Coronal curved planar reformatted image
showing two patent stents inserted at mid and distal segments of
RCA. The distal RCA and PLB are patent. (c) Coronal curved
planar reformatted image showing patent LM, LCx and OM1
with proximal LCx mixed eccentric plaque exerting mild luminal
stenosis.
796 M.A. Dawoud et al.used for global assessment of stent location and native coro-
nary arteries.
Each stent was defined as follows:
– *Patent with no visible neointimal hyperplasia: the absence of
low-attenuation areas between stent wall and contrast
enhanced lumen.– *Patent with insignificant neointimal hyperplasia: longitudi-
nal low-attenuation areas along the stent wall observed as
a rim of hypoattenuation between the stent and the contrast
enhanced vessel lumen exerting <50% stenosis.
– *Patent with in-stent restenosis: longitudinal and transverse
low-attenuation areas along the stent wall exerting P50%
stenosis.
– *In-stent occlusion: the complete absence of contrast mate-
rial within stent lumen. Evaluation of non-stented coronary
arteries: The non-stented coronary arteries were also evalu-
ated to detect areas of significant stenosis (P50) or occlu-
sion that may contribute to recurrent patient’s symptoms.
The lumen assessment was done on looking through
3.0 mm axial MIP images and curved planar reformatted-
images.
Conventional coronary angiography was done in 16 cases
after MDCT on request of cardiologist and cardio-thoracic
surgeon for confirmation and comparison.
Statistical analysis SPSS version 21 (IBM Inc.) was used
which included the following:
– T test for comparison of means for numerical scaling vari-
ables e.g. body measurements.
– Cross tabulation with Fisher’s exact test of significance for
comparison of the nominal variables.
– F statistics for test of variance between and within our stud-
ied groups.
In all these tests, the statistical significance was considered
at 5% level if (P< 0.05).
3. Results
Twenty-four patients were referred for coronary stents assess-
ment, 18 (75%) patients were males while 6 (25%) patients
were females. Their age ranged from 41 to 66 years with a
mean of 56.13 ± 6.69 years.
Patient’s weight and height and BMI measurements are dis-
played in Table 1. None of these body measurements between
the studied groups showed any statistically significant differ-
ences (P> 0.05).
Different risk factors for coronary artery disease were pre-
sent in studied patients including diabetes mellitus, hyperten-
sion, dyslipidemia and smoking. The distribution of risk
factors among the studied groups was not statistically signifi-
cant (P> 0.05) (Table 2).
Among the studied 24 patients, 12 (50%) patients required
heart rate control prior to scan. Their baseline heart rate ran-
ged from 70 to 96 bpm with a mean of 82.4 bpm. After giving
heart rate control medications, their heart rate at time of scan
ranged from 57 to 78 bpm with a mean of 63.71 bpm. Heart
rate remained above 70 bpm at 4 (16.7%) patients due to sub-
optimal response to oral medications used and anxiety. In
those patients, CT acquisition was done using multiple heart
beats to improve temporal resolution with scanning window
set manually to cover 30–80% of the R–R interval.
A total number of 63 coronary artery stents deployed
within 24 patients were included in this study and were evalu-
ated by MSCT. Both drug-eluting and bare metal stents were
assessed with their outer diameter ranged from 2.5 mm to
Fig. 3 59-year old female patient exhibits recurrent chest pain 7 months after PCI to treat severe proximal LAD lesion. (a) Left anterior
oblique view of 3D volume rendered image showing the position of the proximal LAD stent that ends just beyond D1 takeoff which is still
well opacified through the stent. Proximally, the stent encroaches upon LCx takeoff. LAD distal to the stent is patent and the visible
segment of LCx as well. (b) Axial MIP image showing the position of proximal LAD stent. However, the lumen cannot be assessed from
MIP image due to high density struts. A significant mid LAD bifurcation lesion is noted by two opposing mixed plaques exerting moderate
luminal stenosis (50–70%) of mid LAD and D2 ostium. (c) Sagittal curved planar reformatted image showing patent proximal LAD stent.
Mixed plaque is seen distal to stent exerting moderate luminal stenosis. The distal LAD is patent. (d) Coronal curved planar reformatted
image showing patent dominant LCx and PLB. The dense proximal LAD stent is seen encroaching upon LCx takeoff.
Table 1 Body measurements.
Weight (kg) Height (m) BMI
Stent group N = 24
Mean 87.04 1.69 29.76
Std. deviation 9.37 0.04 3.01
Minimum 74 1.64 22
Maximum 110 1.76 38
Std. error 1.91 0.01 0.62
Table 2 Frequency of risk factors.
DM HTN Dyslipidemia Smoking
N % N % N % N %
Stent group
(N = 24)
6 25 6 25 9 37.5 12 50
P-value 0.469 0.133 0.075 0.366
DM: diabetes mellitus, HTN: hypertension.
Evaluation of coronary stents 7975.0 mm. The study included 9 (14.3%) stents with 2.5 mm
diameter, 18 (28.6%) with 3.0 mm diameter, 18 (28.6%) with
3.5 mm diameter, 3 (4.8%) stents with 4.0 mm diameter, 9
(14.3%) stents with 4.5 mm diameter and 6 (9.5%) stents with
5.0 mm diameter.The evaluated stents were deployed within different coro-
nary arterial segments as shown in Table 3.
Among the 63 stents included in this study, only 6 (9.52%)
stents were considered non-interpretable on evaluating MSCT
images due to either small diameter or thick struts that inter-
fere with luminal assessment. Four of those non-
interpretable stents were of 2.5 mm diameter while the other
two were of 3.0 mm diameter. The non-interpretable stents
were distributed at mid LAD (2 stents), distal LAD (one stent)
and proximal OM1 (3 stents). The remaining 57 (90.48%)
stents were considered interpretable where 48 (76.19%) stents
were reported as patent without neo-intimal hyperplasia while
9 (14.29%) stents showed significant in-stent restenosis
(P50%).
According to stent diameter, the results of luminal assess-
ment with MSCT can be classified as shown in Table 4.
According to their distribution at different coronary arte-
rial segments, assessment of stent lumen with MSCT revealed
the following: 9 (14.29%) patent stents at proximal RCA, 6
(9.52%) patent stents at mid RCA, 6 (9.52%) patent stents
at distal RCA, 6 (9.52%) patent stents at proximal LAD, 9
(14.29%) patent stents at mid LAD, 3 (4.76%) patent stents
and mid LCx, 6 (9.52%) patent stents at proximal D2 and 3
(4.76%) patent stents at proximal OM2. These patent stents
showed no evidence of neo-intimal hyperplasia by MSCT.
Significant in-stent restenosis (P50%) was found at 3
(4.76%) stents at proximal LAD, 3 (4.76%) stents at mid
Fig. 4 56-year old male patient exhibits chest pain after multiple PCI settings with insertion of multiple drug eluting stents to treat multi-
vessel disease. (a) Semitransparent 3D volume rendered image showing the position of proximal LAD stent with still opacified three
diagonal branches through it. The mid and distal LAD segments are patent. Also noted the position of OM1 ostial stent, mid LCx stent
and OM2 ostial stent. Both OM1 and OM2 are patent beyond the stents. (b) Curved planar reformatted image showing the entire course
of RCA and PDA. Proximal and distal RCA stents are patent The remaining RCA segments and PDA are free of significant disease. (c)
Curved planar reformatted image showing patent proximal LAD stent. The distal LAD segment as well as the left main coronary artery is
patent. (d) Curved planar reformatted image showing inadequate luminal expansion of OM1 ostial stent with subsequent significant
blooming artifact interfering with luminal assessment. OM1 distally is patent and free of disease. (e) Curved planar reformatted image
showing patent LCx stent and OM2 ostial stent. OM2 distal to stent is patent.
798 M.A. Dawoud et al.LAD and 3 (4.76%) stents at proximal LCx. None of the eval-
uated stents in this study showed neither insignificant (<50%)
in-stent restenosis nor total occlusion. Six (9.52%) non-
interpretable stents were found at 2 (3.17%) stents at mid
LAD, one (1.6%) stent at distal LAD and 3 (4.76%) stents
at proximal OM1.
Conventional coronary angiography was done in 16 cases
after MDCT on request of cardiologist and cardio-thoracic
surgeon for confirmation and comparison. In 16 patients (41
stents) with diameter more than 3 mm 31 stents were diag-
nosed correctly out of 32 diagnosed patents by MDCT and 8
stents out of 9 stenosed stents more than 50% diagnosed accu-
rately by MDCT.4. Discussion
Conventional coronary angiography has been considered the
gold standard for evaluation of coronary artery stents and coro-
nary artery bypass grafts. However, the main drawbacks of this
method include invasiveness, patient discomfort, high radiation
dose and risk of complications. A less invasive imaging modal-
ity is desirable for evaluation of patients suspected to have in-
stent restenosis or occlusion and those who are suspected to
have coronary artery bypass graft stenosis or occlusion (11).
It is not advisable to scan patients whose BMI is above
40 kg (12). In this study, the mean BMI for scanned patients
Fig. 5 59 year old male patient exhibits chest pain after PCI
settings to treat mid LAD and D2 significant lesions. (a)
Semitransparent 3D volume rendered image showing the position
of mid LAD and proximal D2 stents. The distal LAD and D2
segments beyond the stents are patent. Incidentally noted dilated
ascending aorta. (b) Curved planar reformatted image showing
concentric soft plaque at proximal LAD segment exerting stenosis
(60%). The mid-segment LAD stent has thick struts exerting
significant blooming artifact interfering with luminal assessment.
However, LAD segment distal to stent is patent a. (c) Curved
planar reformatted image showing the proximal D2 stent that
appears to be patent. D2 segment beyond the stent is patent. The
mid-segment LAD stent shows significant blooming artifact
interfering with luminal assessment.
Table 3 Distribution of stents within arterial segments.
Arterial segment N %
Proximal RCA 9 14.29
Mid RCA 6 9.52
Distal RCA 6 9.52
Proximal LAD 9 14.29
Mid LAD 14 22.22
Distal LAD 1 1.59
Proximal LCx 3 4.76
Mid LCx 3 4.76
Proximal D2 6 9.52
Proximal OM1 3 4.76
Proximal OM2 3 4.76
Total 63 100
Evaluation of coronary stents 799was 29.76 kg with a range of 22–38. None of the performed
scans was non-interpretable secondary to image noise as the
BMI of the selected patients was still reasonable to perform
coronary CTA.Heart rate control is still essential even with the use of 320-
row multislice CT scanner, not only to obtain good quality
images, but also to lower radiation dose to the patients. The
slower heart rate (665 bpm) improves the temporal resolution
and results in almost motion free images. It also permits the
use of prospective ECG-gating (13).
In a pilot study done by Dewey et al. (14) on 30 patients
who underwent both coronary angiography and coronary
CTA, they found that radiation exposure reduction was great-
est in patients with heart rates 665 bpm, whereas the effective
dose was significantly higher in those with higher heart rates
because of the necessity of acquiring data over multiple cardiac
cycles to increase temporal resolution, highlighting the impor-
tance of b-blockade.
In this study, heart rate control was achieved using oral
medications: either Metoprolol or Ivabradine. With optimum
heart rate control (665 bpm), we were able to scan the patients
with prospective gating method exposing only 70–80% of R–R
interval using single beat acquisition at those with coronary
stents. Only four cases (16.7%) failed to respond well to oral
medications and their heart rate remained above 70 bpm at
time of scan. So, we had to widen the scanning window to
cover 30–80% of R–R interval and to use two beats volume
scanning for those with coronary stents. Even though, the
obtained image quality was not satisfactory and some of the
native coronary arteries were non-interpretable.
The fast heart rate can also lead to failure of coronary stent
lumen assessment and makes interpretation of bypass graft
segments close to the heart difficult secondary to cardiac
motion artifact (14).
Stent lumen visibility varies largely depending on stent type
and diameter. The blooming effect is more disturbing in smal-
ler coronary stents with thicker struts and is less disturbing in
larger stents. Non-interpretable images tend to be obtained in
stents that have thicker struts and/or a smaller diameter. When
the stent diameter is more than 3 mm, lumen visibility is better.
Regarding the type of stent, gold or gold-coated stents, along
with tantalum made stents cause the most severe artifacts,
while stainless steel and cobalt stents are better visualized (15).
Carbone et al. (16) evaluated the ability of 64- detector row
CT to assess the coronary artery stent patency on fifty-five
consecutive patients (age range 45–80 years) with 97 previously
implanted coronary artery stents and the sensitivity, specificity,
positive predictive value and negative predictive value were
75%, 86%, 71% and 89%, respectively. However, nine of
Table 4 MSCT findings according to stent diameter.
Stent diameter 2.5 (mm) 3.0 (mm) 3.5 (mm) 4.0 (mm) 4.5 (mm) 5.0 (mm) Total
Patent 5 13 12 3 9 6 48
Stenosis (P50%) 0 3 6 0 0 0 9
Non-interpretable 4 2 0 0 0 0 6
Total 9 18 18 3 9 6 63
Total 14.3% 28.6% 28.6% 4.8% 14.3% 9.5% 100%
800 M.A. Dawoud et al.the 12 stented segments of 2.5 mm diameter and 10 of the 23
stented segments of 2.75 mm diameter were excluded from
the analysis since these segments were considered as non-
interpretable to blooming artifact.
In another study done by Oncel et al. (15) on thirty patients
with 39 coronary stents using 64-slice CT scanner, nine of the
39 stents were shown to be totally occluded at conventional
angiography. All of the occluded stents were correctly diag-
nosed with CT angiography. Nineteen of 20 patent stents were
correctly demonstrated with CT angiography. Ten stents had
in-stent restenosis; eight were correctly diagnosed with CT.
The sensitivity, specificity, positive predictive value and nega-
tive predictive value were 89%, 95%, 94% and 90%, respec-
tively. However, the stents with a diameter 62.5 mm were
excluded from their analyses and the average stent diameter
was 3.1 ± 0.4 mm. This goes our results. (The sensitivity 89
and specificity 94.)
In another study by Rist et al. (17) twenty-five patients with
46 stents underwent 64-slice CT of the coronary arteries and
coronary angiography after coronary artery stent placement.
Significant in-stent restenosis or occlusion was detected on
coronary angiography in 8 stents (P50% stenosis = 6 &
occlusion = 2). Both of the two occluded coronary stents were
correctly identified, while two of the six stents with non-
occlusive stenoses were misdiagnosed as patent. The diameters
of these two misdiagnosed stents were 2.5 and 3.0 mm, respec-
tively. These findings indicated that non-occlusive in-stent rest-
enoses were undetected in some cases, and especially for stents
with a smaller diameter, even with using 64-detector row CT.
A recently done study by de Graaf et al. (8) using 320-row
MDCT scanner on 53 patients with a total of 89 stents was
available for evaluation. They concluded that stents with
diameter <3 mm as well as stents with strut thickness
P140 mlm were associated with decreased CTA image quality
and diagnostic accuracy.
Among the 63 stents that have been evaluated in this study,
only 6 stents (9.52%) were considered non-interpretable. Four
of them are 2.5 mm in diameter while the remaining two are of
3.0 mm diameter. The difficulty in interpretation of 2.5 mm
stents in this study was due to small stent caliber that makes
accurate lumen visualization difficult. Their struts were thin
and did not exert significant blooming artifact. One stent of
the same diameter was not interpretable secondary to inade-
quate stent expansion which is probably a technical error dur-
ing stent deployment. On the other hand, the two stents with
3.0 mm diameter were not interpretable secondary to thick
struts that exert much blooming and beam hardening artifacts
making lumen visualization difficult even with bone window
settings, sharp reconstruction kernel and high kV and mA
setting.The remaining 57 stents in this study were interpretable by
MSCT and their lumen was clear enough to rule-out or diag-
nose in-stent restenosis. Some of those stents had thick struts
that exert blooming artifact. However, the blooming artifact
could be minimized by using sharp reconstruction kernel, bone
window setting and small field of view and the lumen was
clearly visualized.
A biodegradable stent with dense radio-opaque markers
was evaluated by MSCT in this study, the blooming artifact
exerted by those markers was not interfering with stent luminal
assessment and in-stent restenosis was ruled out easily.
Based on stent location, stents located at proximal seg-
ments of RCA, LAD and LCx were better visualized than
those deployed within the distal segments of the same arteries
and also than those deployed within obtuse marginal and diag-
onal branches owing to large caliber of the former and small
caliber of the later stents.
Cardiac motion artifact was not a contributing factor in
difficult stent lumen evaluation in this study as the mean heart
rate of stent group was 63 bpm which is considered slow
enough to create motion free images and in the same studies
that contain non-interpretable stent, the native coronary arter-
ies were completely assessable. However, most authors (18)
stated that heart rate should be kept below 60 bpm for better
quality images when evaluating cases with coronary artery
stents.
In this study, MSCT was capable not only of stent lumen
evaluation to rule-out in-stent restenosis, but also was helpful
in diagnosing significant disease at non-stented coronary arter-
ies and detection of plaque composition either soft, calcified or
mixed plaque. MSCT was capable of detecting serious inciden-
tal extracardiac findings such as ascending aortic aneurysm
that could be missed during conventional coronary angiogra-
phy. Another interesting finding was the detection of the site
of myocardial infarction
A major drawback of retrospectively ECG-gated MDCT
data acquisition is the radiation dose. Since the data are
acquired with an overlapping helical pitch and continuous
X-ray exposure, the applied radiation dose is higher than that
in the prospectively ECG-triggered sequential acquisition.
When compared with the mean effective dose values calculated
for conventional coronary angiography, the mean effective
dose with multi-detector row CT angiography was higher by
a factor of about five. However, by reducing the tube current
during cardiac cycle phases that are not likely to be used for
image interpretation, a dose reduction of up to 48% is possible
according to Jakobs et al. (18). To reduce radiation dose in this
study, we used prospective helical acquisition only exposing
70–80% of R–R interval in those with heart rate below
Evaluation of coronary stents 80165 bpm, and 30–80% of R–R interval in those with heart rate
above 65 bpm.
Compared with conventional angiography, CT angiogra-
phy is less costly, faster to perform, does not require assembly
of an angiographic team to perform the study, generally avail-
able 24 h a day and can be considered as an outpatient proce-
dure. It permits a wider variety of manipulations of the
volumetric data set for image display and analysis in contrast
to the limited projections routinely obtained during conven-
tional angiography, and has fewer potential complications.
Moreover, CT images can be reconstructed to yield 3D volume
rendered images that give much anatomical and pathological
details in contrast to conventional angiography that only visu-
alizes lumen (19).
In our study using 320-row CT scanner, the mean scan time
was about 5 s while it was 30 s with 16 section scanner and 20 s
in 64 section scanner thus improving image quality by acquir-
ing data from fewer heart beats and the study becomes tolera-
ble by most patients due to short breath hold time. The shorter
scan time also allowed much reduction in the volume of con-
trast material.
5. Conclusion
*Multi-detector CT is considered convenient and reliable non-
invasive imaging modality for assessment of suspected coro-
nary stents with large diameter
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